Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain
Clinical trial NCT01864265 · COMPLETED
Trial details
- NCT number
- NCT01864265
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2019-06-30
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.